Rinvoq ER 30 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB25FEGLU
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $69,383
Award facts
- Contract value 100% obligated
- $69,382.88 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $69,382.88 to AmerisourceBergen Drug Corp for RINVOQ ER 30 mg tablets (quantity: 30 units). This firm fixed-price, non-set-aside contract was awarded on August 19, 2025, with an ultimate completion date of August 20, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. RINVOQ ER is a prescription medication used primarily for rheumatoid arthritis and other inflammatory conditions, representing part of the Defense Logistics Agency's ongoing pharmaceutical supply requirements for military and veteran healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor that supplies brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support military healthcare programs worldwide. The company's competitive standing and extensive portfolio of federal contract awards demonstrate its capability to fulfill diverse and time-sensitive pharmaceutical supply needs for the Defense Logistics Agency and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FEGLU?
SPE2DB25FEGLU was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 19, 2025.
How much is contract SPE2DB25FEGLU worth?
The government has obligated $69,383 on SPE2DB25FEGLU.
Is contract SPE2DB25FEGLU an order under another contract?
Yes. SPE2DB25FEGLU is a delivery order under SPE2DB24D2205, an indefinite delivery contract.
Was contract SPE2DB25FEGLU competed?
The extent of competition for SPE2DB25FEGLU was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award